ChemoCentryx Shares Spike 300% on Phase 3 ANCA Vasculitis Trial Results
Source: Streetwise Reports  (11/26/19)
Shares of ChemoCentryx Inc. opened greater than 330% higher today after the firm reported positive topline data from its pivotal Phase 3 ADVOCATE trial of Avacopan in treatment of ANCA-associated vasculitis. More >

Regenerative Medicine Firm Advances Multifaceted Pipeline
Source: Streetwise Reports  (11/26/19)
The company continues advancing its cell therapies and medical device. More >

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment
Source: Streetwise Reports  (11/25/19)
Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. More >

EyeGate Pharma Shares Looking Up on Pivotal PRK Ocular Bandage Gel Study Data
Source: Streetwise Reports  (11/22/19)
EyeGate Pharmaceuticals shares opened nearly 85% higher today after the company reported select topline data demonstrating that it met its primary endpoint in its cornea wound repairs pivotal photorefractive keratectomy study using the firm's Ocular Bandage Gel eye drop. More >

Cannabis Firm's Stock Poised for 'Substantial Gains'
Source: Clive Maund for Streetwise Reports  (11/21/19)
Technical analyst Clive Maund charts how news from this company affects its investment thesis. More >

Hepion Pharma Shares Climb 50% Higher on NASH Liver Disease Treatment Results
Source: Streetwise Reports  (11/21/19)
Shares of Hepion Pharmaceuticals opened higher today after the company reported that its anti-fibrotic agent CRV431 prevented the development of liver cirrhosis in a highly aggressive, preclinical liver disease model. More >

ICAN Leverages Leading California Brand with Expansion into Nevada, Introduces State-of-the-Art Pre-Roll Machine, for Aggressive Near-Term Growth
Source: Knox Henderson for Streetwise Reports  (11/20/19)
A recent acquisition is helping this company to expand its brand. More >

Kiniksa Pharma Awarded FDA Breakthrough Therapy Status for Pericarditis Treatment Drug
Source: Streetwise Reports  (11/20/19)
Shares of Kiniksa Pharmaceuticals opened nearly 30% higher today after the firm reported that the FDA granted Breakthrough Therapy designation for Rilonacept for the treatment of recurrent pericarditis. More >

Myovant Sciences Shares Up 110% on Phase 3 Advanced Prostate Cancer Data
Source: Streetwise Reports  (11/19/19)
Shares of Myovant Sciences opened 120% higher today after the firm reported a 97% response rate in its Phase 3 HERO Study of oral Relugolix in men with advanced prostate cancer. In the study, Relugolix achieved all six key secondary endpoints and the firm expects to submit a New Drug Application in Q2/20. More >

Medical Small Cap Moving Forward with Cutting-Edge Technological Innovations
Source: Streetwise Reports  (11/18/19)
Premier Health is methodically building an innovative telemedicine platform in Canada, is purchasing a venerable telemedicine firm, and sees 2020 as the year of execution. More >

Firm to Acquire CBD Products Designer
Source: Streetwise Reports  (11/18/19)
The deal encompasses all of the company's brands, formulations and processes. More >

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data
Source: Streetwise Reports  (11/18/19)
Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. More >

Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia
Source: Streetwise Reports  (11/15/19)
With antibiotic resistance a major health issue, the search is on for effective alternatives to replace antibiotics in livestock feed to promote growth. More >

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring
Source: Streetwise Reports  (11/15/19)
Plus Therapeutics shares opened 25% higher today after the firm reported Q3/19 financial and business results. In the most recent quarter, the company completed the change of its name, relocated its headquarters to Austin, and raised $15 million for R&D and working capital. More >

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher
Source: Streetwise Reports  (11/14/19)
Shares of Exicure Inc. opened 30% higher today after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure with the potential to grow to $750 million. More >

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes
Source: Knox Henderson for Streetwise Reports  (11/13/19)
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. More >

Biopharma Presents Data on Alcoholic Hepatitis Therapeutic at Liver Meeting
Source: Streetwise Reports  (11/13/19)
The company intends to follow up in 2020 with a Phase 2b clinical trial. More >

FDA Approval of Peanut Allergy Treatment Expected Next Year
Source: Streetwise Reports  (11/13/19)
The current status, catalysts and outlook for the immunotherapy are discussed in a ROTH Capital Partners report. More >

Clinical Trial Results for Alcoholic Hepatitis Drug Delivered in Webcast
Source: Streetwise Reports  (11/13/19)
The online presentation coincides with The Liver Meeting 2019, at which data also are shared. More >

Electromed Earnings Spark a 25% Increase in Its Share Price
Source: Streetwise Reports  (11/13/19)
Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. More >

Seachange in Mexico on Cannabis Could Benefit This Small Cap
Source: Clive Maund for Streetwise Reports  (11/13/19)
Technical analyst Clive Maund highlights a small-cap that may be poised to benefit from the recent Mexican Supreme Court decision on cannabis. More >

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device
Source: Knox Henderson for Streetwise Reports  (11/12/19)
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. More >

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue
Source: Streetwise Reports  (11/12/19)
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher today after the firm announced Q3/19 financial and operational results. More >

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results
Source: Streetwise Reports  (11/8/19)
Shares of Iovance Biotherapeutics traded 12% higher today after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. More >

Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High
Source: Streetwise Reports  (11/7/19)
Glucose monitoring systems developer Dexcom's shares traded 30% higher today after releasing Q3/19 earnings and raising full-year 2019 guidance. More >